Norihiro Suzuki
Chief Excutive Director
Kure Kyosai Hospital
JapanResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Norihiro Suzuki is the Chief Executive Director at Shonan Keiiku Hospital in Japan. His recent research primarily focuses on the efficacy and safety of fremanezumab for migraine prevention, demonstrated through multicenter, randomized trials involving Japanese and Korean patients. His contributions to the field highlight long-term safety and tolerability concerns regarding migraine treatment options.
Articles (3)
Year:
2021
Year:
2021
Year:
2021
Collaborators (2)
YUKI ISOGAI
Cardiology, Medical Science / Section chief
Otsuka Pharmaceutical
JAPAN
Nobuyuki Koga
Specially Appointed Associate Professor
Tokushima University
JAPAN
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.